[Federal Register Volume 79, Number 238 (Thursday, December 11, 2014)]
[Notices]
[Pages 73628-73629]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-29117]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Johnson 
Matthey Pharmaceutical Materials, Inc.

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Johnson Matthey Pharmaceutical Materials, Inc. applied to be 
registered as a manufacturer of certain basic classes of controlled 
substances. The DEA grants Johnson Matthey Pharmaceutical Materials, 
Inc. registration as a manufacturer of the controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated January 15, 2014, and 
published in the Federal Register on February 4, 2014, 79 FR 6633, 
Johnson Matthey Pharmaceutical Materials, Inc., Pharmaceutical Service, 
25 Patton Road, Devens, Massachusetts 01434, applied to be registered 
as a manufacturer of certain basic classes of controlled substances. No 
comments or objections were submitted to this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823(a) and determined that the registration of 
Johnson Matthey Pharmaceutical Materials, Inc. to manufacture the basic 
classes of controlled substances is consistent with the public interest 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. The DEA 
investigated the company's maintenance of effective controls against 
diversion by inspecting and testing the company's physical security 
systems, verifying the company's compliance with state and local laws, 
and reviewing the company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Nabilone (7379)............................  II
Hydrocodone (9193).........................  II
Alfentanil (9737)..........................  II
Remifentanil (9739)........................  II
Sufentanil (9740)..........................  II
------------------------------------------------------------------------

    The company plans to utilize this facility to manufacture small 
quantities

[[Page 73629]]

of the listed controlled substances in bulk and to conduct analytical 
testing in support of the company's primary manufacturing facility in 
West Deptford, New Jersey. The controlled substances manufactured in 
bulk at this facility will be distributed to the company's customers.

    Dated: November 25, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-29117 Filed 12-10-14; 8:45 am]
BILLING CODE 4410-09-P